Artificial Intelligence Augmented Ultrasound for Developmental Dysplasia of the Hip: a Validity Study
Sponsor: Murdoch Childrens Research Institute
Trial Details
| Condition | Developmental Dysplasia of Hip |
| Intervention | Artificial intelligence augmented ultrasound |
| Phase | NA |
| Status | Recruiting |
| Participants | 240 |
| Est. Completion | 1 Nov 2026 |
| Last Updated | 8 Apr 2026 |
Primary Outcome
Artificial Intelligence augmented ultrasound screening test capability: Sensitivity; Artificial Intelligence augmented ultrasound screening test capability: Specificity; Artificial Intelligence augmented ultrasound screening test capability: Positive predictive value (PPV); Artificial Intelligence augmented ultrasound screening test capability: Negative predictive value (NPV)
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Enrolled in the VicHip study * Is 4-20 weeks of age at enrolment * Is attending The Royal Children's Hospital for the purpose of the potential diagnosis of DDH * Has a diagnostic (standard) hip ultrasound on the day of their out-patient appointment * Has a legally acceptable representative capable of understanding the informed consent document and providing consent on the participant's behalf. Exclusion Criteria: Participants will be excluded from enrolment if: • They are currently receiving treatment for DDH
Trial Sites
🇦🇺 Australian Sites (1)
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service